In March 2025, the company declared new strategies to get a direct-to-customer featuring of its Wegovy weight loss drug. The company established a completely new pharmacy, referred to as NovoCare, which might demand prospects $499 per month for entry to the drug, lower than half the expense of the drug by means of other pharmaceutical distribution